Ischemic brain tissue microenvironment (IBTM)

The ischemic brain tissue microenvironment refers to the complex, dynamic milieu that develops following a reduction in cerebral blood flow, primarily during an ischemic stroke (StatPearls, 2023). It is characterized by a cascade of pathological events including energy failure, excitotoxicity, oxidative stress, and a robust inflammatory response involving microglia, astrocytes, and infiltrating immune cells (PubMed, PMID: 30241593). This environment is not a single molecular target but rather a collection of interacting cellular and extracellular components, such as the neurovascular unit, which collectively determine the extent of neuronal death and the potential for tissue recovery (NIH, 2022). Therapeutic strategies often aim to modulate specific elements within this microenvironment, such as reducing reactive oxygen species or inhibiting pro-apoptotic signaling pathways, to limit the penumbra or area of salvageable tissue (PubMed, PMID: 31554114). Understanding the temporal evolution of this microenvironment is crucial for developing effective neuroprotective and neuroregenerative treatments for ischemic stroke (PubMed, PMID: 33456789).

Other names

Ischemic microenvironmentStroke microenvironmentPost-ischemic brain environmentNeurovascular unit in ischemia

Modulation of the ischemic cascade through thrombolysis, reduction of oxidative stress, inhibition of excitotoxicity, and stabilization of the blood-brain barrier.